Virtual Art Therapy for Adolescent and Young Adult Cancer Survivors (AVATARS Trial)
This study, called the AVATARS Trial, is testing a virtual art therapy program to help adolescent and young adult (AYA) cancer survivors (ages 10-25) feel better after cancer treatment. Many AYA survivors experience challenges like anxiety and depression. This art therapy aims to help with these feelings, improve resilience, and process difficult experiences. You would participate in virtual art therapy sessions, and after completing them, you'd receive a 3D printed replica of your artwork. The main goal is to see if this program is practical, easy to use, and helpful for survivors. The study is looking to enroll 30 participants who have had a cancer diagnosis in the past year or finished treatment within the last five years, and who experience mild or greater depression.
- Study design
- This is an interventional study with a planned enrollment of 30 participants. It is not specified if it's randomized or blinded.
- What's involved
- You would complete four virtual art therapy sessions, each lasting over 60 minutes, every 1-2 weeks. You would also complete surveys and interviews.
- Compensation
- Not stated in the trial record.
- Follow-up
- After completing the study treatment, you would be followed up at 1 and 2 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
At a glance
Conditions
NCT07089927
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mayo Clinic in Arizona
Scottsdale, Arizonastudy coordinator listed
Recruiting
Mayo Clinic in Rochester
Rochester, Minnesotastudy coordinator listed
Not yet recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- C. Robert Bennett, PhD, RN · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility-EnrollmentUp to 4 months
Assessed via the percentage of eligible participants who enroll in this study.
- Feasibility-CompletionUp to 4 months
Assessed via the percentage of participants who complete at least 75% of the intervention sessions.
- Intervention Usability ScaleUp to 4 months
Assessed by the Intervention Usability Scale. It is a 10-item questionnaire with questions answered on a 5-point scale where 1 = strongly disagree and 5 = strongly agree. Higher scores indicate greater usability.
- Acceptability-Exit InterviewUp to 6 months
Participants will be invited to provide feedback about their experience during brief (e.g., 20- 30 minute) scripted open-ended question exit interviews. Participants perspectives about the intervention, administration format, and schedule will be used to refine the intervention.
- Change in AnxietyT1 (at baseline within 48 hours of recruitment), T2 (within 72 hours post session two, and T3 (within 72 hours post session four), T4 (1 month post session four), and an optional measement at T5 (2 months post session four
Assessed via State-Trait Anxiety Inventory. This is a 20-item questionnaire related to the current anxiety. Questions are answered on a scale of 1 to 4 where 1 = none at all, 2= a little, 3 = somewhat and 4 = very much so. Higher scores indicate greater feelings of anxiety.
- Change in DepressionT1 (at baseline within 48 hours of recruitment), T2 (within 72 hours post session two, and T3 (within 72 hours post session four), T4 (1 month post session four), and an optional measement at T5 (2 months post session four
Assessed via Patient Health Questionnaire for Adolescents (PHG-A). This is a 13-item questionnaire related to feelings of depression. Questions 1-9 relate to the last two weeks and are answered on a scale of 0 to 3 where 0=Not at all, 1=Several days, 2=More than half of the days and 3=Nearly every day. Lower scores indicate lesser feelings of depression. Two questions relate to feelings of depression over the past year, and two questions relate to suicidal thoughts.
- Change in ResilienceT1 (at baseline within 48 hours of recruitment), T2 (within 72 hours post session two, and T3 (within 72 hours post session four), T4 (1 month post session four), and an optional measement at T5 (2 months post session four
Assessed via Connor Davidson Resilience Scale 10 (CD-RISC-10), a 10-item questionnaire related to resilience over the past month. Questions are answered on a scale of 0 to 4, where 0=not true at all, 1=rarely true, 2=sometimes true, 3=often true and 4=true nearly all the time. Higher scores indicate greater resilience.
- Change in Emotional regulationT1 (at baseline within 48 hours of recruitment), T2 (within 72 hours post session two, and T3 (within 72 hours post session four), T4 (1 month post session four), and an optional measement at T5 (2 months post session four
Assessed via Difficulties in Emotion Regulation Scale (DERS), a 36-item questionnaire related to difficulties in emotional regulation. Questions area answered on a 5-point scale (almost never to almost always). A higher score indicates greater difficulties in emotional regulation.